Dr. Federica Martorana received her Medical Doctor degree and her PhD from the School of Medicine and Surgery, University of Catania. She gained her specialization in oncology from the University of Messina. She completed the Global Clinical Scholarship Research Training (GCSRT) at Harvard Medical School. Her research interests mainly include the molecular biology of breast cancer, with a specific focus on target therapies, resistance to target therapies, hereditary breast cancer, molecular analysis of thyroid tumors (either primary or secondary to chemo-radiotherapy exposure during childhood), clinical research, and new drug development.